AntagomiR-based therapy for Myocardial infarction: MiRNA Let-7g decreases myocardial survival post myocardial infarction via down regulation of aldehyde dehydrogenase 2, 19/August/2014, 08.27 am

AntagomiR-based therapy for Myocardial infarction: MiRNA Let-7g decreases myocardial survival post myocardial infarction via down regulation of aldehyde dehydrogenase 2, 19/August/2014, 08.27 am

AntagomiR-based therapy for Myocardial infarction: MiRNA Let-7g decreases myocardial survival post myocardial infarction via down regulation of aldehyde dehydrogenase 2, 19/August/2014, 08.27 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, L., AntagomiR-based therapy for Myocardial infarction: MiRNA Let-7g decreases myocardial survival post myocardial infarction via down regulation of aldehyde dehydrogenase 2, 19/August/2014, 08.27 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Pharmacological relevance: This study suggests that pharmacological formulations encompassing “Let-7g inhibitors” may be used to increase myocardial survival post myocardial infarction.
 * Research cooperation